Aplenzin (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the Aplenzin drug offered from sanofi-aventis U.S. LLC. This Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
NON-PROPRIETARY NAME: | bupropion hydrobromide |
SUBSTANCE NAME: | BUPROPION HYDROBROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-03-30 |
END MARKETING DATE: | 0000-00-00 |
Aplenzin HUMAN PRESCRIPTION DRUG Details:
Item Description | Aplenzin from sanofi-aventis U.S. LLC |
LABELER NAME: | sanofi-aventis U.S. LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 522(mg/1) |
START MARKETING DATE: | 2009-03-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0024-5812_c25bf565-8061-450a-9217-a7a280ee0424 |
PRODUCT NDC: | 0024-5812 |
APPLICATION NUMBER: | NDA022108 |
Other BUPROPION HYDROBROMIDE Pharmaceutical Manufacturers / Labelers: